Müllhaupt, Gautier http://orcid.org/0000-0002-5725-5608
Hechelhammer, Lukas
Diener, Pierre-André
Engeler, Daniel S.
Güsewell, Sabine
Schmid, Hans-Peter
Mordasini, Livio
Abt, Dominik
Funding for this research was provided by:
Research committee of the cantonal hospital of St. Gallen (14/08 and 15/16)
Article History
Received: 18 May 2019
Accepted: 21 November 2019
First Online: 7 December 2019
Compliance with ethical standards
:
: Boston Scientific (Natick, MA, USA) provided Embozene microspheres for the patients in the proof-of-concept study assessing PAE in localized prostate cancer free of charge. The company did not influence design, conduct, and analysis of the study. DA: Research support (institutional): Olympus, Boston Scientific, Advisory role (institutional): Janssen, Travel support (institutional): Janssen, Debiopharm. GM: Travel support: Debiopharm.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.